Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Generics will lower prices by 25% and increase competition
When in doubt, contact your healthcare provider
Explore what this shift could mean for your benefits strategy #ViaBenefits #GLP1 #Medicare To view or add a comment, sign in New Medicare guidance is reshaping access to GLP-1 drugs for obesity, with implications for cost, coverage and plan design
Compounded versions may be offered at lower prices, but the trade-off is potential variability in quality and effectiveness
Retatrutide timing introduces additional complexity because retatrutide activates three receptors (GLP-1, GIP, and glucagon)
US$ 21.28
US$ 25.50
US$ 26.30
US$ 20.32
